ENDOMETRIAL CARCINOMA STAGE III

Clinical trials for ENDOMETRIAL CARCINOMA STAGE III explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL CARCINOMA STAGE III trials appear

Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Custom cancer vaccine trial uses 'Quantum' tech to target tumors

Disease control ENROLLING_BY_INVITATION

This early-phase trial is testing a personalized vaccine for people with high-risk or recurrent endometrial cancer. The vaccine is custom-made for each patient based on the unique genetic markers of their tumor, with the goal of training their immune system to fight the cancer. A…

Matched conditions: ENDOMETRIAL CARCINOMA STAGE III

Phase: EARLY_PHASE1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ENDOMETRIAL CARCINOMA STAGE III

Get alerted when new ENDOMETRIAL CARCINOMA STAGE III trials appear

Custom cancer vaccine trial uses 'Quantum' tech to target tumors